Hauck & Aufhaeuser set a €55.00 ($67.90) target price on Gerresheimer (ETR:GXI) in a research note released on Tuesday. The brokerage currently has a sell rating on the stock.

Other equities research analysts have also issued reports about the company. JPMorgan Chase & Co. set a €99.40 ($122.72) target price on Gerresheimer and gave the company a buy rating in a research report on Wednesday, October 11th. Berenberg Bank set a €75.00 ($92.59) target price on Gerresheimer and gave the company a buy rating in a research report on Wednesday, October 11th. Credit Suisse Group set a €80.00 ($98.77) target price on Gerresheimer and gave the company a buy rating in a research report on Tuesday, October 10th. Commerzbank set a €77.00 ($95.06) target price on Gerresheimer and gave the company a buy rating in a research report on Monday, October 23rd. Finally, set a €65.00 ($80.25) target price on Gerresheimer and gave the company a neutral rating in a research report on Tuesday, October 17th. Two analysts have rated the stock with a sell rating, five have given a hold rating and five have given a buy rating to the company’s stock. Gerresheimer currently has a consensus rating of Hold and a consensus target price of €71.61 ($88.41).

Shares of Gerresheimer (ETR GXI) opened at €66.20 ($81.73) on Tuesday. The stock has a market capitalization of $2,080.00 and a P/E ratio of 46.95. Gerresheimer has a one year low of €59.97 ($74.04) and a one year high of €78.25 ($96.60).

COPYRIGHT VIOLATION WARNING: This story was originally published by Watch List News and is the property of of Watch List News. If you are reading this story on another publication, it was stolen and republished in violation of U.S. and international copyright & trademark laws. The correct version of this story can be read at https://www.watchlistnews.com/gerresheimer-gxi-given-a-55-00-price-target-at-hauck-aufhaeuser/1849751.html.

About Gerresheimer

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.